Natera, Inc. (NTRA)
Nasdaq: NTRA · Services-Medical Laboratories · Austin, TX · filing with the SEC since 2014
Grade6.6
◀ Past 5.8● Present 6.5▶ Future 7.5
Filings
286 filings since 2017 beside 1,433 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 23, 2026.
Filings a yearinsider forms included
142147180165158236270279
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Jul 6, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 16, 2026
8-K/A items 5.02, 9.01
Officer or director change · Current report, amended
Jun 2, 2026
Jun 16, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 11, 2026
Dec 5, 2025
8-K items 3.02, 8.01, 9.01
Shares sold without registration; Other event · Current report
Dec 4, 2025
40 of 286 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.